Prothrombin G20210A
Prothrombin G20210A (pronunciation: pro-throm-bin G20-210A) is a genetic mutation that increases the risk of developing abnormal blood clots in veins, a condition known as venous thromboembolism.
Etymology
The term "Prothrombin" is derived from the Greek words "pro" meaning "before" and "thrombos" meaning "clot". The "G20210A" refers to the specific location of the mutation on the gene.
Overview
Prothrombin, also known as factor II, is a protein produced by the liver and is essential for the blood clotting process. The Prothrombin G20210A mutation involves a change in the prothrombin gene, where guanine (G) is replaced by adenine (A) at position 20210. This mutation results in higher levels of prothrombin in the blood, increasing the risk of developing blood clots.
Related Terms
- Venous thromboembolism: A condition in which blood clots form in the veins.
- Factor II: Another name for prothrombin.
- Thrombophilia: A condition where the blood has an increased tendency to form clots.
- Deep vein thrombosis: A type of clot that forms in a major vein of the leg or, less commonly, in the arms, pelvis, or other large veins in the body.
- Pulmonary embolism: A condition that occurs when a blood clot gets lodged in an artery in the lung, blocking blood flow to part of the lung.
See Also
External links
- Medical encyclopedia article on Prothrombin G20210A
- Wikipedia's article - Prothrombin G20210A
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski